Bring Vaccines to Market Faster

Trusted Vaccine Industry Partner for Over 20 Years

2nd Annual mRNA Quality Control & Compliance Summit
June 25-27, 2024
Boston, MA

 

Visit us at the booth!

June 26, 1:50 pm ET

mRNA Vaccine Characterization: Multivalent Identity, Integrity, and Quantity Analytics using VaxArray

Amy R. Johnson, PhD
SE US Business Development Manager
InDevR

What you’ll learn about:

  • InDevR’s VaxArray is an easy-to-use, benchtop platform aimed at reducing vaccine development and manufacturing bottlenecks by bringing mRNA analytics to your laboratory.
  • Measure Critical Quality Attributes (CQAs) including 5’ capping efficiency, identity, and quantity in multivalent naked and LNP-encapsulated mRNA mixtures in <2 hours
  • VaxArray’s inherent flexibility in capture type and configuration enables assay creation and customization for a wide variety of vaccine and therapeutic analytics.

Simplify 5′ Capping Measurements

Current vaccine manufacturers measure 5′ capping efficiency using complex chromatographic methods that can take 1-2 days with additional queue and analysis time. Reduce analytical turnaround times during mRNA vaccine development and measure 5′ capping efficiency in your laboratory with the 5’CapQ Assay.

  • Get Results Faster – Simplify testing with technology providing highly reproducible results in less than two hours.
  • Analysis at Your Benchtop – Reduce testing bottlenecks by bringing mRNA analytics to your facility.
  • Less Expertise Required – Standardize characterization of your mRNA vaccines on an easy-to-use microarray-based platform.

Maximize Efficiency in Vaccine Development with VaxArray

Discover the VaxArray Platform, your solution in multiplexed immunoassays designed to streamline vaccine development and analysis. This state-of-the-art system offers unparalleled precision and efficiency, empowering researchers to achieve faster, more reliable results in their efforts to advance public health.

  • Multiplex 50+ Analytes in Triplicate – VaxArray multiplexed technology outpaces traditional single-plex methods like ELISA in speed and efficiency.
  • Results in 1 Hour – Faster time to result compared to other technologies.
  • Versatile Platform – analyze a wide range of vaccine-relevant samples, from antibodies and antigens to nucleic acids.

Custom VaxArray for mRNA

Partner with InDevR for comprehensive mRNA customized solutions to simplify mRNA vaccine analytics and accelerate your path to market. InDevR’s Expert Services Team will create custom multiplexed assays to measure mRNA Critical Quality Attributes (CQA) in one platform.